Regardless of the significant progress made in surgical techniques and adjuvant therapies,
brain tumors are a major contributor to cancer-related morbidity and mortality in both …

Background: Glioblastoma (GBM) tumors are rich in tumor-associated microglia/
macrophages. Changes associated with treatment in this specific cell population are poorly …

Glioblastoma (GBM) is a highly invasive, aggressive brain cancer that carries a median
survival of 15 months and is resistant to standard therapeutics. Recent studies have …

Knee osteoarthritis (OA), a prevalent joint disease in the US, poses challenges in terms of
predicting of its early progression. Although high-resolution knee magnetic resonance …

Background Non-enhancing (NE) infiltrating tumor cells beyond the contrast-enhancing (CE)
bulk of tumor are potential propagators of recurrence after gross total resection of high-grade …

Representation of tumor growth in clinically-relevant contexts has generally been explored
via three main types of models: continuum models that simulate tissue-scale behavior …

Glioblastoma (GBM) is a highly invasive, aggressive brain cancer that carries a median
survival of 15 months. This poor prognosis is due, in part, to its resistance to standard …